RYRIX Performance — Retailing Fund, Investor Class
Data updated: 2026-08-28
RYRIX returned −2.03% year to date and +4.29% over one year to Jun 2026. Annualised returns are +10.25% over 3 years and +1.09% over 5 years. The fund trailed its Consumer Discretionary Equity category average: $100 invested three years ago grew to $134, against $146 for the category, and to $104 over one year, against $110. Volatility over the past three years was 16.57% a year. In the 12 months to Jun 2026 the fund lost a net $2.3M, and assets reached $4.55M.
RYRIX Growth of $100
What $100 invested in Retailing Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Consumer Discretionary Equity category average over the same months.
| Period | RYRIX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $104 | $110 |
| 3 years (Jul 2023 – Jun 2026) | $134 | $146 |
| 5 years (Jul 2021 – Jun 2026) | $106 | $119 |
| Since data start (Jul 2019 – Jun 2026) | $189 | $204 |
RYRIX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −2.03% |
| 1 year | +4.29% |
| 3 years (annualised) | +10.25% |
| 5 years (annualised) | +1.09% |
RYRIX Annual Returns
Calendar-year total returns of Retailing Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | −2.03% |
| 2025 | +9.72% |
| 2024 | +15.87% |
| 2023 | +17.11% |
| 2022 | −25.91% |
| 2021 | +12.36% |
| 2020 | +44.72% |
| 2019 (Jul–Dec) | +7.43% |
RYRIX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.4% | −1.5% | −6.1% | +5.9% | −3.6% | +0.3% | — | — | — | — | — | — |
| 2025 | +4.9% | −2.9% | −6.0% | −0.3% | +6.1% | +1.7% | +3.2% | +3.6% | +1.9% | −2.7% | +1.1% | −0.7% |
| 2024 | −3.0% | +9.6% | +3.6% | −7.4% | +5.9% | −0.7% | +1.2% | −0.5% | +6.5% | −3.6% | +7.0% | −2.4% |
| 2023 | +11.7% | −4.9% | 0.0% | −0.5% | −5.2% | +8.6% | +4.6% | −4.2% | −7.5% | −2.8% | +9.5% | +9.1% |
| 2022 | −8.5% | −4.7% | −0.3% | −7.8% | −6.9% | −7.5% | +10.9% | −1.9% | −8.0% | +5.9% | +9.3% | −7.4% |
| 2021 | +2.6% | +2.1% | +4.7% | +4.0% | −2.5% | +3.5% | −1.8% | +1.7% | −5.1% | +5.3% | −1.1% | −1.0% |
| 2020 | −2.4% | −5.0% | −14.2% | +19.3% | +11.3% | +4.4% | +8.9% | +7.9% | −2.4% | −0.6% | +11.9% | +3.0% |
| 2019 | — | — | — | — | — | — | +1.2% | −1.6% | +2.0% | +1.6% | +2.3% | +1.8% |
RYRIX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 16.57%
- 3-year Sharpe ratio: 0.35 (vs 4.5% risk-free rate)
- Best month: +9.62% (Feb 2024)
- Worst month: −7.45% (Sep 2023)
RYRIX Fund Flows
Monthly money in and out of Retailing Fund, from SEC Form N-PORT.
- 12-month net flow: −$2.3M
- 12-month gross sales (incl. reinvestments): $15.5M
- Sales ÷ redemptions: 0.87×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $82K | $205K | −$124K |
| May 2026 | $33K | $980K | −$947K |
| Apr 2026 | $16K | $18K | −$2K |
| Mar 2026 | $121K | $399K | −$278K |
| Feb 2026 | $708K | $1.7M | −$1.0M |
| Jan 2026 | $395K | $331K | $64K |
| Dec 2025 | $1.7M | $1.1M | $586K |
| Nov 2025 | $2.2M | $6.4M | −$4.2M |
| Oct 2025 | $4.6M | $199K | $4.4M |
| Sep 2025 | $746K | $1.8M | −$1.1M |
| Aug 2025 | $3.0M | $1.8M | $1.2M |
| Jul 2025 | $1.8M | $2.7M | −$946K |
RYRIX Assets Under Management
Net assets of Retailing Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $4.55M |
| 2026-03-31 | $5.46M |
| 2025-12-31 | $6.91M |
| 2025-09-30 | $6.50M |
| 2025-06-30 | $6.76M |
| 2025-03-31 | $6.83M |
| 2024-12-31 | $7.70M |
| 2024-09-30 | $10.19M |
| 2024-06-30 | $10.01M |
| 2024-03-31 | $7.46M |
| 2023-12-31 | $6.30M |
| 2023-09-30 | $8.29M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.